ScreenerHero

BOI Boiron SA

EPA · FR · Healthcare · Drug Manufacturers - Specialty & Generic · boiron.fr
19.00EUR-4.04%Mkt Cap: 358.57M $P/E: 12.58

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, i…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap358.57M USD
Enterprise Value344.47M USD
Revenue (TTM)538.89M USD
Gross Profit397.53M USD
Net Income (TTM)35.48M USD
Revenue/Share28.55 EUR
Last Price19.00 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2.6K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)12.58
P/E (Forward)9.30
PEG2.38
EV/EBITDA5.59
EV/Revenue0.64
P/S0.69
P/B0.92
EPS (TTM)1.51
EPS (Forward)2.13
52W Range
18.801% of range32.25
52W High32.25 EUR
52W Low18.80 EUR
Profitability
Gross Margin72.98%
Oper. Margin3.96%
EBITDA Margin11.44%
Profit Margin6.51%
ROE8.31%
ROA5.42%
Growth
Revenue Growth-2.20%
Earnings Growth-56.80%
Cash Flow & Leverage
Operating CF57.87M USD
CapEx (TTM)25.57M USD
FCF Margin5.56%
FCF Yield8.35%
Net Debt-29.21M USD
Net Debt/EBITDA-0.47
Balance Sheet
Debt/Equity0.08
Current Ratio2.25
Quick Ratio1.29
Book Value/Sh21.62 EUR
Cash/Share2.92 EUR
Dividends
Fwd Div Rate1.35 EUR
Trail. Div Rate1.35 EUR
Div. Yield6.82%
5Y Avg Yield3.10%
Payout Ratio89.40%
Ex-Div DateJun 3, 2026
Pay Date—
Splits
Last Split4:1
Split DateJul 1, 2003
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.17.36M
Float3.50M
Insiders79.00%
Institutions4.90%
Technical
SMA 5024.96 (-23.9%)
SMA 20027.14 (-30.0%)
Beta0.21
S&P 52W Chg14.58%
Avg Vol (30d)4.31K
Avg Vol (10d)4.78K
Technical Indicators
RSI (14)21.1
MACD-1.6958
MACD Signal-1.4942
MACD Hist.-0.2017
BB Upper28.49 EUR
BB Middle22.69 EUR
BB Lower16.89 EUR
BB Width51.16%
ATR (14)0.7989 EUR
Vol Ratio (20d)1.00x